the aid library

LIST OPTIONS

Filter

2779

Sort by:

Direction:

Download (199)

View PDF (343)

Tuberculosis in Blacks

Centers for Disease Control and Prevention; National Center for HIVAIDS; TB Prevention; et al. (2013) C_CDC

June 2013

Download (347)

View PDF (355)

TB Elimination Tuberculosis Information for Employers in Non-Healthcare Settings

Centers for Disease Control and Prevention; National Center for HIVAIDS; TB Prevention; et al. (2012) C_CDC

January 2012

Download (914)

View PDF (1898)

Ebola virus disease preparedness strengthening team Senegal country visit 17–21 November 2014

World Health Organization (2015) C_WHO

The immediate objective of the country visit to Senegal was to build upon the public health preparedness already in place and to ensure that systems are available to investigate and report potential EVD cases and to mount an effective response to prevent a larger outbreak. The joint team for strengt... more

Download (205)

View PDF (422)

Guidelines for screening for Tuberculosis infection and disease during the domestic medical examination for newly arrived refugees

U.S. Department of Human Services; Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectios Diseases (2012) C_CDC

Division of Global Migration and Quarantine April 16, 2012

Download (1099)

View PDF (1453)

Tuberculosis Infection Control in the Era of Expanding HIV Care and Treatment: Addendum to WHO Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings

Center for Disease Control and Prevention, World Health Organisation (2007)

The goal of this addendum is to help management and staff  minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,  and/or support, and b.) there is a high prevalence of HIV infection, both known  and... more

Download (365)

View PDF (429)

West Nile Virus in the United States: Guidelines for Surveillance, Prevention, and Control

Centers for Disease Control and Prevention (2013)

Download (316)

View PDF (738)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Flyer

Ministry of Health and Social Services (MOHSS) , PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

The Namibia Population-based HIV Impact Assessment (NAMPHIA) 2017 | The Ministry of Health and Services is leading the NAMPHIA survey in collaboration with the Namibia Statistics Agency (NSA) and the Namibia Institute of Pathology (NIP). The survey is supported by the United States President’s Eme... more

Download (374)

View PDF (686)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Brochure

Ministry of Health and Social Services (MOHSS), PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

Download (308)

View PDF (593)

CS258303 National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases Help Control Mosquitoes that Spread Dengue, Chikungunya, and Zika Viruses

National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases (CDC) (2015) CC

Download (431)

View PDF (355)

WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals

World Health Organization WHO (2019) C_WHO

Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med... more

Download (328)

View PDF (487)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Poster

Ministry of Health and Social Services (MOHSS), PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

Download (92)

View PDF (148)

Belgian Antibiotic Policy Coordination Committee Policy paper for the 2014-2019 term

Erica Balligand, Michiel Costers and Evelyne Van Gastel Belgian Antibiotic Policy Coordination Committee (2014) C2

Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo... more

Download (61)

View PDF (83)

Global Adult Tobacco Survey: Executive Summary 2016

World Health Organization WHO (2016) C_WHO

Ethiopia GATS was implemented by Ethiopia Public Health Institute (EPHI) in collaboration with the Ethiopian Food, Medicine, Health Care Administration and Control Authority (FMHACA), CSA, FMOH and the World Health Organization (WHO)country office. Technical assistance ... more

Download (136)

View PDF (202)

Testing for tuberculosis infection and screening for tuberculosis disease among incoming refugees from Ukraine to European countries

European Centre for Disease Prevention and Control ECDC (2022) C1

7 April 2022. Aimed at national policymakers, public health and healthcare planners, staff working in reception centres, and healthcare staff caring for displaced persons, the information note concludes that universal testing of incoming refugees from Ukraine for tuberculosis (TB) infection is not r... more

Download (242)

View PDF (222)

Ensuring health security in the African region - Emergency preparedness and response flagship programmes

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re... more

Download (76)

View PDF (316)

Union Africaine Échange d'Information Sur La Santé Lignes Directrices et Normes

Africa Center for Disease Control and Prevention (2023) CC

L'application de la technologie de santé numérique se développe rapidement en Afrique, dans le but d'améliorer la prestation des services de santé et d'atteindre plus efficacement les communautés éloignées et mal desservies. D'autre part, l'absence de lignes directrices et de normes da... more

Download (72)

View PDF (301)

Troca de Informacao Sobre Saude Diretrizes e padrões

Africa Center for Disease Control and Prevention (2023) CC

A aplicação da tecnologia digital de saúde está crescendo rapidamente na África, com o objetivo de melhorar a prestação de serviços de saúde e alcançar de forma mais eficaz comunidades remotas e carentes. A falta de diretrizes e padrões habilitadores em todo o continente, por outro ... more

Download (109)

View PDF (129)

Ensuring health security in the African region: Emergency preparedness and response flagships progress report #4

World Health Organisation (WHO) (2022) C_WHO

The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship initiatives to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the r... more

Download (158)

View PDF (162)

Cadre continental sur le renforcement des systèmes de surveillance de la mortalité en Afrique

Africa Center for Disease Control and Prevention (2023) CC

L'importance de systèmes de surveillance de la mortalité robustes ne peut être surestimée à une époque marquée par des défis sanitaires mondiaux croissants, où les menaces sanitaires pèsent lourd et la dynamique des populations continue d'évoluer. Des données précises et opportunes sur ...la mortalité sont essentielles pour identifier les tendances et détecter les menaces émergentes pour la santé, évaluer l'impact des interventions et orienter les décisions politiques fondées sur des données probantes. Ce cadre décrit une approche holistique pour renforcer les systèmes de surveillance de routine de la mortalité, en tenant compte des facteurs contextuels uniques et des défis auxquels sont confrontés les pays africains. Il souligne l'importance d'établir des mécanismes de collecte de données efficaces, d'améliorer la qualité et l'exhaustivité des données et de promouvoir le partage des données et la collaboration entre les parties prenantes. De plus, le cadre reconnaît le rôle central de la technologie dans l'intégration des données provenant de sources de données fragmentées sur la mortalité. Il met en évidence le potentiel des méthodes innovantes de capture de données, des analyses avancées et des systèmes de notification en temps réel pour améliorer la précision, l'efficacité et l'actualité des données sur la mortalité. Le cadre continental de surveillance de la mortalité s'aligne sur la mission et l'objectif stratégique d'Africa CDC en servant d'élément fondamental dans le renforcement des systèmes de santé publique, l'amélioration des capacités et des capacités de surveillance des maladies, l'élaboration de politiques et d'interventions fondées sur des données probantes et la promotion de la collaboration et de la coordination entre les pays africains pour relever les défis sanitaires et améliorer les résultats sanitaires sur le continent. La mise en œuvre réussie de ce cadre nécessite un engagement collectif et des efforts concertés de la part des gouvernements, des établissements de santé et de la communauté internationale. Nous espérons que ce document servira de catalyseur pour un changement transformateur, permettant aux pays de mettre en place des systèmes de surveillance de la mortalité résilients qui protègent la santé publique, sauvent des vies et contribuent à la prise de décision fondée sur des données probantes. more

Download (6)

View PDF (5)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more